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Abstract: We report the structural characterization of a new pyrazinone analogue; 
butrepyrazinone, which was isolated from a new actinomycete strain Verrucosispora sp. 
K51G recovered from Ghanaian mangrove river sediment. Spectroscopy-guided 
fractionation led to the isolation of a compound from the fermentation culture and  
a combination of NMR spectroscopy, high-resolution mass spectrometry and computer-aided 
calculations revealed that butrepyrazinone (10) possesses an unusual methylation pattern 
on the pyrazinone ring. Butrepyrazinone (10), however, displayed no antibacterial activity 
against Gram-positive S. aureus ATCC 25923, the Gram-negative E. coli ATCC 25922 
and a panel of clinical isolates of methicillin-resistant S. aureus (MRSA) strains, 
suggesting that 10 may act as a signal molecule for this strain. Although the same molecule 
has been synthesized previously, this is the first report to disclose the discovery of 
butrepyrazinone (10) from nature. 
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1. Introduction 
The pyrazinone ring is a non-aromatic heterocyclic ring with two nitrogens that are situated para- to 
each other. Chemically, they are derived from the aromatic pyrazine ring by single oxidation of one of 
the carbon atoms as opposed to double oxidation, which gives the diketopiperazine ring common in the 
structures of many drugs in current use. A gradually growing number of microbes have been cited in 
the literature for their ability to biosynthesize pyrazinone compounds. Examples of microbes from 
which pyrazinones have been characterized include: Methicillin resistant Staphylococcus aureus 
phevalin (1), tyrvalin (2) and leuvalin (3) [1,2] and Streptomyces sp. phevalin (1), arglecin (5),  
argvalin (4), JBIR-56 (6), and JBIR-57 (7) [3,4]. It appears that pyrazinones are derived from the 
multidomain non-ribosomal peptide synthetase (NRPS) assembly line, which involves a reduction in 
the final step to generate dipeptide aldehyde, followed by cyclization of imine functionality promoted 
by nucleophilic attack of the aldehyde by the α-amine of one amino acid [3,4]. Hence, the C-5 of the 
pyrazinone ring is mostly un-substituted (1–5 in Figure 1). While the absence of a substituent in the  
C-5 of the pyrazinone ring is understandable, based on the current literature available, there exists 
another group of pyrazinone compounds that possess substituents on both the C-5 and C-6 carbons of 
the pyrazinone skeleton (Figure 1). For example, JBIR-56 (6) and 57 (7), maremycin E (8) and F (9) 
possess C-5 and C-6 substituents through biosynthetic mechanisms that are not clear [3–5]. 
Figure 1. Substitution patterns in pyrazinone compounds isolated from microbes. 
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During our investigations of several Micromonospora sp. derived from sediments collected from 
the Butre River in the western region of Ghana, we came across a Verrucosispora sp. K51G, which 
was found to produce a new pyrazinone butrepyrazinone (10) (Figures S1 and S2). The structure of 
butrepyrazinone (10) is typical of what is currently known to characterize the naturally occurring 
pyrazinone compounds. However, butrepyrazinone (10) possesses two methyl substituents at both the 
C-5 and C-6 positions rendering its biosynthesis difficult to understand completely. 
In this communication, we describe the taxonomy and large-scale fermentation of the producing 
strain and the extraction, isolation, physico-chemical characterization, antimicrobial screening and the 
structure determination of butrepyrazinone (10). 
2. Results and Discussion 
2.1. Sediment Sample Collection Sites 
The western region of Ghana is particularly noted for large stretches of mangroves that have 
become characteristically embedded in the life of the natives. An important river, called the Butre, cuts 
across a large section of these mangroves before entering the sea. We collected sediment samples from 
the river at four different sites approximately 100 m apart. Verrucosispora sp K51G was isolated from 
one of these sediments (coordinates: 4°49′56.19ʺ N and 1°54′52.00ʺ W). 
2.2. Taxonomy of Strain Verrucosispora sp. K51G (Genbank Number KM196613) 
An almost-complete 16S rDNA gene sequence for strain K51G (1461 nt) was determined and 
compared with corresponding sequences of all recognized species within the genus Verrucosispora [6] 
and related taxa in the family Micromonosporaceae [7–9]. 
The strain showed greater than 98% 16S rDNA gene sequence similarity to the type strains of 
recognized species of the genus Verrucosispora, but in the neighbor-joining phylogenetic tree  
(Figure 2) based on 16S rDNA gene sequences it formed a distinct phyletic line. The isolate showed 
the highest level of 16S rDNA gene similarity with the type strain of Verrucosispora lutea YIM013T 
(98.44%, a value that corresponded to 22 nucleotide differences at 1414 locations). Relatively high 
similarity values were shown with the type strains of V. wenchangensis 234402T (98.29%), V. fiedleri 
MG37T (98.28%), V. gifhornensis DSM44337T (98.28%), V. maris AB18032T (98.22%), V. sediminis 
MS426T (98.20%) and V.andamanensis SP03-05T (98.07%). According to the phylogenetic analysis, 
the strain is clearly distinguished from the other members of the genus Verrucosispora and could be 
representing a new species within the genus Verrucosispora. 
2.3. Structure Determination of Compound 10 (Butrepyrazinone) 
A seven-day grown seed culture of Verrucosispora sp was used in the inoculation of two L starch 
casein media in the presence of the Diaion HP-20 resin (50 g/L medium). After 28-day fermentation, 
the aqueous solution was filtered and HP20 resin was extracted with methanol (3 × 500 mL).  
The crude extract was concentrated under vacuum and followed by partition using a modified Kupchan 
method [10]. The purification was achieved through Sephadex LH-20 chromatography (GE 
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Healthcare, Little Chalfont, UK) followed by semi-preparative reversed-phase HPLC resulting in the 
isolation of 10 (6.2 mg). 
Figure 2. Neighbor-joining tree based on nearly complete 16S rDNA gene sequences 
(1461 nt) showing relationships between isolate K51G and representatives of genera 
classified in the family Micromonosporaceae. Asterisks indicate branches of the tree that 
were also found using the maximum-likelihood and maximum-parsimony tree-making 
algorithms. The numbers at the nodes indicate levels of bootstrap support (%) based on a 
neighbor-joining analysis of 1000 re-sampled datasets; only values at or above 50% are 
given. T type strain, Bar 0.01 substitutions per nucleotide position.  
 
Butrepyrazinone was isolated as a colorless amorphous powder soluble in chloroform.  
The HRESIMS of this compound gave m/z = 215.1178 (M + H)+ and 237.0998 (M + Na)+ indicating a 
molecular formula of C13H14ON2 ( = +0.030 ppm) with 8 degrees of un-saturation. Analysis of the 
1H, 13C and multiplicity edited gHSQCAD spectra suggested the presence of 5 quaternary, 5 methine, 
1 methylene and 2 methyl carbons. With the aid of the 1H-13C gHSQCAD data (Table 1) all protons 
were assigned to their directly bonded carbon atoms. The presence of three aromatic protons at δH 7.40 
(2H, d, J = 6 Hz, H-9/9′), 7.25 (2H, t, J = 6 Hz, H-10/10′) and 7.18 (1H, t, J = 6 Hz, H-11) suggested a 
 Verrucosispora andamanensis SP03-05T (JX524154) 
 Verrucosispora  wenchangensis 234402T (HQ123435) 
Verrucosispora sediminis MS426T (EU870859) 
 Verrucosispora  lutea YIM 013T (EF191199) 
 Verrucosispora fiedleri MG-37T (JQ423921) 
 Verrucosispora gifhornensis HR1-2 T (Y15523) 
 Verrucosispora maris AB-18-032 T (CP002638) 
 Verrucosispora sp. K51G (KM196613) 
 Verrucosispora qiuiae RtIII47T (EU427445) 
 Jishengella endophytica 202201T (EU560726)  
 Salinispora tropica CNB-440T (CP000667)  
 Salinispora arenicola CNS-205 T (CP000850) 
 Polymorphospora rubra TT97-42T (AB223089) 
 Plantactinospora mayteni YIM 61359T (FJ214343)     
 Actinaurispora siamensis CM2-8T (AB454379)  
 Spirilliplanes yamanashiensis IFO 15828T (D63912) 
 Krasilnikovia cinnamomea 3-54(41)T (AB236956)  
 Pseudosporangium ferrugineum 3-44-a-19T (AB302183)  
 Asanoa ferruginea IFO 14496T (D86944)  
 Phytohabitans suffuscus K07-0523T (AB490769)  
 Catenuloplanes japonicus IFO 14176T (D85476)  
 Catelliglobosispora koreensis LM 042T (AF171700)  
 Prauserella rugosa DSM 43194T (AF051342) 
99 
97 
93 
58 
54 
89 
91 
56 
99 
68 
60 
0.01 
* 
* 
* 
* 
* 
* 
* 
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mono-substituted benzene ring with the proton at δH 4.10 (2H, s, H-7) strongly indicating a methylene 
benzylic position borne between two rings. The corresponding δC resonances for this mono-substituted 
benzene ring and attached methylene benzylic moiety were observed at δC 129.9 C-9/9′,  
128.8 C-10/10′, 126.9 C-11 and 39.6 C-7 respectively. Further confirmation of the first sub-structure 
obtained from the 1D NMR analysis was placed on 1H-1H gCOSY data for H-7/H-9,9′, H-9,9′/H-7,  
H-10,10′, H-10,10′/H-9,9′ and H-11/H-9,9′ reinforced by gHMBCAD peaks from C-7 to H-9,9′, C-9,9′ 
to H-7, H-10,10′, H-11, C-10,10′ to H-9,9′ and C-11 to H-9,9′. Another pronounced feature of the  
1H NMR spectrum of butrepyrazinone is the presence of the methyl protons δH 2.28 (3H, s, H-13) and 
δH 2.21 (3H, s, H-12) which by their chemical shifts and multiplicity were indicative of methyl groups 
situated on quaternary sp2 hybridized carbon atoms. Using the δC data 157.5 C-2, 154.6 C-3, 132.2 C-5 
and 129.9 C-6 the pyrazinone ring with two methyl substituent was constructed based on careful 
examinations of chemical shifts, unsaturation number of 4, and gHMBCAD data correlations C-2 to  
H-7, C-3 to H-7, H-12, C-5 to H-12, H-13 and C-6 to H-13, H-12. Furthermore, a gCOSY correlation 
from H-7/H-12 put the placement of the methyl groups on C-5 and C-6 beyond all reasonable doubt. 
All NMR data obtained for this compound are summarized in Table 1. 
Table 1. 1H and 13C NMR data of butrepyrazinone in CDCl3. δ in ppm, J in Hz. 
Position δH Mult (J Hz) δC Mult HMBC 
NH-1    
2 
 
157.5, C 7 
3 
 
154.6, C 7, 12 
N-4  
  
5  132.2, C 12, 13 
6  129.9, C 13, 12 
7 4.10, s 39.6, CH2 9, 9′ 
8  138.3, C 7, 10, 10′ 
9/9′ 7.40, d (6) 129.9, (CH)2 7, 10, 10′, 11 
10/10′ 7.25, t (6) 128.8, (CH)2 9, 9′ 
11 7.18, t (6) 126.9, CH 9, 9′ 
12 2.21, s 16.7, CH3 
 
13 2.28, s 18.9, CH3 
 
Further confirmation of the structure was performed by calculating all possible structures using the 
ACD/LABS Structure Elucidator [11] software as follows: The proton NMR and 2D NMR data 
including Edited-gHSQCAD, gCOSY, gHMBCAD and ROESY, the molecular formula plus a 
predetermined mono-substituted benzene ring were entered into the software. Non-standard 
correlations [12] were detected notably in the gCOSY correlation between H-7 and H-12, and in the 
HMBC correlations between C-3 and H-12, and C-8 and H-12. These were automatically resolved by 
the software and calculations resulted in 14 possible structures (Figure S8) of which the proposed 
structure was placed as the best possible candidate (Figures 3 and 4). The low number of the chemical 
shift deviations of the HOSE-code (dA) [13], Incremental Method (dI) [14], and Artificial Neural Net 
(dN) [14] 13C chemical shifts indicate that the proposed structure is correct. 
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Figure 3. Selected COSY data for butrepyrazinone. 
 
Figure 4. The best candidate structure calculated by the Structure Elucidator with 13C 
chemical shift deviations between experimental and predicted of the HOSE-code (dA) 
Incremental Method (dI) and Artificial Neural Net (dN). 
 
Scheme 1. Proposed biosynthetic pathway of butrepyrazinone from Verrucosispora sp. 
K51G. NRPS: Non-ribosomal peptide synthetase; A: Adenylation domain; T: Thiolation 
domain; C: Condensation domain; Re: NADH-dependent reduction domain. 
 
2.4. Proposed Biosynthetic Pathway for Butrepyrazinone 
Based on the chemical logic of other pyrazinones in the literature [1,3], we proposed the 
biosynthesis of butrepyrazinone as shown in Scheme 1. A multidomain non-ribosomal peptide 
synthetase should be involved in the biosynthesis of butrepyrazinone, and the assembly line is likely to 
use one phenylalanine and one alanine unit with the reduction reaction in the final step to generate the 
dipeptide aldehyde (11), which is cyclized to afford the imine intermediate (12) (Scheme 1). The imine 
intermediate is further oxidized and methylated to generate butrepyrazinone. The last two steps could 
result from two different enzymes, oxidase and SAM-dependent methyl transferase. However, one 
should not exclude the possibility of one hybrid enzyme with two functional domains. This can be 
exemplified from a recent report of the identification of an epoxidase C-methyltranferase bifunctional 
fusion protein PsoF in the biosynthetic pathway of Aspergillal polyketide natural products Pseurotins [15]. 
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In vitro studies demonstrated that PsoF, a single polypeptide containing a methyl transferase (MT) and 
a FAD-dependent monooxygenase (FMO), can act as a trans C-methylation of the backbone of the 
growing polyketide chain and catalyze the stereospecific epoxidation in the late stage of the 
biosynthesis [15]. 
2.5. Antibacterial Activity of Butrepyrazinone 
Butrepyrazinone was tested for its antibacterial activity against the Gram-positive S. aureus ATCC 
25923, the Gram-negative E. coli ATCC 25922 and a panel of clinical isolates of methicillin-resistant 
S. aureus (MRSA) strains (Table 2). The compound, up to 25 μg/mL, did not show antibacterial activity 
against any strain while rifampicin was distinctly active with MIC values (0.001–0.01 μg mL−1). 
Table 2. Strains used in antibacterial screening of butrepyrazinone. 
Strain Source of Isolate 
S. aureusATCC 25923 a ATCC 
E. coli ATCC 25922 a ATCC 
SMRSA 105 Toe wound 
SMRSA 124 Open wound 
SMRSA 116 Knee abscess 
EMRSA 15 Urine infection 
a Laboratory strains. 
All clinical isolates were obtained from the NHS Grampian Microbiology Diagnostic Laboratory, 
Aberdeen Royal infirmary. 
Abbreviations: EMSRA = epidemic MRSA, SMRA = Scottish MRSA. 
3. Experimental Section 
3.1. General Experimental Procedures 
NMR data were acquired on a Varian VNMRS spectrometer operating at 600 MHz for proton and 
150 MHz for carbon. High-resolution mass spectrometric data were obtained using a Thermo 
Instruments MS system (LTQ XL/LTQ Orbitrap Discovery, Thermo Scientific, Bremen, Germany) 
coupled to a Thermo Instruments HPLC system (Accela PDA detector, Accela PDA autosampler and 
Accela pump, Thermo Scientific, Bremen, Germany). The following conditions were used: Capillary 
voltage 45 V, capillary temperature 260 °C, auxiliary gas flow rate 10–20 arbitrary units, sheath gas 
flow rate 40–50 arbitrary units, spray voltage 4.5 kV, mass range 100–2000 am (maximum resolution 
30,000). HPLC separations were carried out using a Phenomenex Luna reverse-phase (C18 250 ×  
10 mm, L × i.d., Phenomenex, Macclesfield, UK) column connected to a Waters 1525 Binary HPLC 
pump Chromatograph (Waters, Milford, MA, USA) with a 2998 PDA detector (Waters, Milford, MA, 
USA), column heater and in-line degasser. Detection was achieved on-line through a scan of 
wavelengths from 200 to 400 nm. Diaion HP-20 was obtained from Resindion S.R.L., a subsidiary of 
Mitsubishi Chemical Co., Binasco, Italy. All solvents used throughout were HPLC-grade and 
purchased from Sigma-Aldrich (Taufkirchen, Germany) through a Ghana-based agent (Huge Limited, 
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Accra, Ghana). Sephadex LH-20 (25–100 μm) was purchased from GE Healthcare (Little Chalfont, 
UK). TLC Silica gel plates (60 F254 nm) were purchased from Merck KGaA (Darmstadt, Germany). 
3.2. Identification of Verrucosispora sp K51G 
Genomic DNA of strain K51G was purified with a DNA extraction kit (Zymo Research, Irvine, CA, 
USA). PCR amplification of the 16S rDNA gene was performed with Go Taq Hot Start master mix 
(Promega Corp., Madison, WI, USA) according to the manufacturer’s instructions. The almost 
complete (1461 bp) 16S rDNA gene sequence of strain K51G was determined by using ABI PRISM 
3730 XL automatic sequencer (Applied Biosystems, Foster City, CA, USA). Pairwise levels of 
similarity of the nearly complete 16S rRNA gene sequence of strain K51G were determined on the 
EzTaxon-e Server (Chunlab Inc., Seoul, South Korea) by using identity analysis [16]. Multiple 
alignments with sequences from closely related species were performed by using the program 
CLUSTAL W in the MEGA6 software package [17]. Phylogenetic tree was constructed with the 
neighbor joining (NJ), maximum-likelihood (ML), maximum-parsimony (MP) algorithms in [18–20]. 
Evolutionary distances were calculated using model of Jukes and Cantor (1969) [21]. Topologies of 
the resultant trees were evaluated by bootstrap analysis [22] based on 1000 re-samplings. 
3.3. Isolation of Verrucosispora sp K51G and Preliminary Screening of the Secondary Metabolites 
Sediment sample was collected from the Butre River in the western region of Ghana (coordinates: 
4°49′56.19ʺ N and 1°54′52.00ʺ W). Verrucosispora sp. K51G was isolated from the swampy 
mangrove sediment using the procedure outline as follows. A small portion of the sediment was 
transferred into sterile 50 mL tubes, covered and the cap wrapped tightly with cellophane to prevent 
the entry of water or steam. The tube containing sample was then immersed in a water bath set at 
temperature 55 °C and heated for 3 h to eliminate non-sporulating bacteria. The sample was then 
suspended in 10 mL of sterile water under a clean bench and filtered using a previously autoclaved 
filter paper. The resultant filtrate was serially diluted to 10−1, 10−2 and 10−3 of the original volume. 
Subsequently, 50 μL of each of the three dilutions were transferred to previously prepared casein 
starch agar plates (agar, 15 g; soluble starch, 10 g; dibasic potassium phosphate, 2 g; potassium nitrate, 
2 g; sodium chloride, 2 g; casein, 0.3 g; magnesium sulfate heptahydrate, 0.05 g; calcium carbonate, 
0.02 g; iron sulfate heptahydrate, 0.01 g; sea salt, 33 g and 1 L of tap water) supplemented with 
nalidixic acid and nystatin at 2.5 μg/L each. This medium is highly recommended for the detection and 
subsequent culture for saccharolytic marine bacteria and actinomycetes. Different colonies of 
Micromonospora sp. were observed after three weeks of incubation at 28 °C. Subsequently, each 
colony was repeatedly transferred and streaked on different fresh casein starch plates with the aid of 
autoclaved tooth picks until pure strains were obtained. One individual bacteria colony from strain 
Verrucosispora sp. K51G was fermented in 50 mL of starch casein liquid media using previously 
autoclaved 250 mL Erlenmeyer flasks plugged with non-absorbent cotton wool. The culture was 
allowed to grow for ten days at 28 °C with continues agitation at 200 rpm. Diaion HP-20 (50 g/L) was 
added to the culture three days prior to harvesting. The culture was then filtered under suction through 
a piece of glass wool placed in a Buchner funnel and the filtrate was discarded. The Diaion HP-20 
resins were then soaked repeatedly and alternatively in CH3OH and CH2Cl2 and the resultant extracts 
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were combined and dried under vacuum to give the crude extract. The extract was then subjected to 
HPLC/HRESIMS analysis. Analysis of the resultant data from HPLC/HRESIMS revealed three minor 
and one major peak for m/z indicating the presence of butrepyrazinone. This mass was entered as a 
query in the Natural Products Identifier AntiBase 2013 software (Wiley, Chichester, West Sussex, UK) 
to check whether this molecule was new or novel. The search came with no relevant hits and the 
Verrucosispora sp. K51G was tagged as one of the interesting strains for further investigation. 
3.4. Large Scale Fermentation of Verrucosispora sp. K51G 
A pure colony of Verrucosispora sp. K51G was used to inoculate a 250 mL Erlenmeyer flask 
containing 50 mL of liquid starch casein media as described above but without agar. After seven days 
of incubation at 28 °C with continuous agitation at 200 rpm, the culture was used to inoculate two 2 L 
conical flasks containing already autoclaved 1 L starch casein liquid media and plugged with  
non-absorbent cotton wool. The two 2 L flasks were incubated at 28 °C with continuous agitation at 
250 rpm for three weeks. Diaion HP-20 resin (50 g/L) was added under sterile conditions using a 
serological pipette to both flasks after three weeks and returned back to the incubator set at 28 °C for 
another one week of continuous agitation at 250 rpm. After four weeks of incubation, the two 1 L 
cultures were harvested and filtered under pressure using a piece of glass wool placed in a Buchner 
funnel. The filtrate was discarded and the residue consisting mainly of the Diaion HP-20 resin with 
adsorbed organics was repeatedly and alternatively extracted with CH3OH and CH2Cl2. The CH3OH 
and CH2Cl2 extracts were combined and concentrated under reduced pressure to give 768 mg of a light 
yellow total crude extract (TCE). 
3.5. Extraction, Isolation and Purification of Compound 
The TCE was suspended in 150 mL of H2O and extracted three times with the same volume of CH2Cl2. 
The CH2Cl2 layer (425 mg) was dried under vacuum and suspended in a 200 mL (9:1 v/v) mixture 
of methanol and water. This mixture was then placed in a 1 L separating funnel and extracted three 
times with the same volume of hexane. The 9:1 v/v mixture of methanol and water was phase adjusted 
to 5:5 v/v methanol and water by adding 160 mL of water to the 9:1 v/v methanol water mixture.  
The 5:5 v/v methanol water mixture was then extracted three times with the same volume of CH2Cl2. 
The CH2Cl2 layer was then dried under vacuum to give 130 mg of extract. This extract was 
subsequently loaded on a gravity column packed with Sephadex LH-20 (GE Healthcare Little 
Chalfont, UK) and eluted with a 5:5 v/v mixture of CH3CN and CH3OH. Four fractions were collected 
from the Sephadex LH-20 run and labeled SF1-4. HPLC/HRESIMS showed that SF2 (45 mg) 
contained the compound of interest. This fraction was therefore subjected to HPLC separation and 
purification using a Phenomenex Luna C18 column (C18 250 × 10 mm, L × i.d., Phenomenex, 
Macclesfield, UK). Gradients of H2O: CH3CN (100% H2O to 100% CH3CN in 30 min and hold for  
20 min) were used as eluent with column flow rates set at 1.5 mL/min to afford butrepyrazinone  
(6.2 mg). 
Butrepyrazinone (10): Colorless amorphous powder; UV (CH3OH), λmax: 230, 338 nm.; IR (neat) 
νmax: 2361, 2340, 2330, 1992, 1648, 749 cm−1; 1H NMR (CDCl3, 600 MHz) and 13C NMR (CDCl3, 
150 MHz) data, see Table 1; HRESIMS m/z 214.1178 (calcd. for C13H14ON2, 214.1178). 
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3.6. Antibacterial Activity of Butrepyrazinone 
The antibacterial activity of butrepyrazinone was evaluated against S. aureus ATCC 25923, E. coli 
ATCC 25922 and a panel of methicillin-resistant S. aureus clinical isolates obtained from the NHS 
Grampian Microbiology Diagnostic Laboratory using slight modifications of the previously described 
method [23]. In brief, bacterial strains were grown in Müller-Hinton (MH) broth [24] to early 
stationary phase and then diluted to an OD620 = 0.1. The assays were performed in a 96-well micro titer 
plate format. Rifampicin and butrepyrazinone were dissolved in DMSO (Sigma, Taufkirchen, 
Germany), and the effect of different dilutions in broth on the growth was assessed after 18 h 
incubation at 37 °C using a Labsystems iEMS Reader MF plate reader (MTX Lab System, Vienna, 
VA, USA) at OD620. The MIC was determined as the lowest concentration showing no growth 
compared to the MH broth control. DMSO up to 10% was shown to have no antibacterial effect. 
4. Conclusions 
Butrepyrazinone was isolated from Verrucosispora sp. K51G recovered from a sediment collected 
from the Butre River, which is situated in the western region mangroves of Ghana. This represents the 
first report of a pyrazinone compound from a Verrucosispora sp. The compound, butrepyrazinone did 
not show any antibacterial activity against the Gram-positive S. aureus ATCC 25923, the  
Gram-negative E. coli ATCC 25922 and a panel of clinical isolates of methicillin-resistant S. aureus 
strains and rightfully so. This lack of activity is fully in-line with the current experimental data that 
suggests that, these compounds do not have detectable antibacterial activity but seem to play a role in 
the chemical interaction between S. aureus, or other skin microbes, and the host. While the structure of 
butrepyrazinone has been previously synthesized [25–29] it is very interesting to realize that this 
compound is actually a natural product produced by a very rare strain of marine actinomycetes.  
Under the current circumstance, a study of the biosynthesis and biological function of this compound 
in the Verrucosispora sp is of utmost interest. 
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